A hospital sued for 700 million won ($523,500) for medical negligence resulting in cerebral infarction has been released from liability. The court found that the medical staff did their best under the circumstances.The Seoul Central District Court recently dismissed all of the patient's claims for d
Korea gained fame during the Covid-19 pandemic for its proactive response in producing Covid-19 diagnostic kits which greatly helped curb the spread of the virus within the country. Now, AItheNutrigene is trying to revolutionize the diagnostics field with its novel lab-on-paper (LOP) diagnostic kit.
The Korea Disease Control and Prevention Agency (KDCA) will downgrade the Covid-19 pandemic from Level 2 to Level 4, the lowest of the country's infection level, on Aug. 31, the agency's chief said on Wednesday.The move comes after cases in the country have been finally slowing down.According to the
Celltrion Healthcare said that more than 10 U.S. insurers have included its Avastin biosimilar Vegzelma (ingredient: bevacizumab), indicated for in their formulary listings.Vegzelma is indicated to treat six types of cancer -- metastatic colorectal cancer; recurrent or metastatic non-squamous non-sm
Celltrion said in a public filing on Tuesday that it received partial approval from the European Medicines Agency (EMA) for part 1 of its global phase 3 clinical trial plan for CT-P53, its multiple sclerosis biosimilar.As of Jan. 31, the European clinical trial regulation has been amended to integra
Tension is rising in the medical community as the quarantine authorities move to downgrade the infectious disease level of Covid-19 soon.When the crisis level is adjusted, and quarantine measures are relaxed, the burden on the healthcare system is bound to increase. There are also concerns about the
Competition for the hemophilia A treatment market intensifies as GC Biopharma takes a shot at hemophilia A drug Hemlibra (emicizumab) sold by JW Pharmaceutical over safety concerns, and JW Pharm responds with a rebuttal.On Monday, GC distributed a press release titled "Hemlibra thrombotic adverse ev
The Ministry of Food and Drug Safety (MFDS) has designated HeartMedi, AiMEDiC’s cardiovascular risk assessment software that evaluates the degree of stenosis of coronary arteries, and DrNoon CKD, Mediwhale’s hospital treatment software that displays the risk of chronic kidney disease, as the 41st an
Discussions on reimbursing the neurofibromatosis drug Koselugo (selumetinib), designated Korea’s first fast-track drug and approved by the Ministry of Food and Drug Safety, have been stalled for over two years.At its eighth meeting earlier this month, Drug Reimbursement Evaluation Committee under th
A joint study conducted by researchers from Severance Hospital and Korea University Anam Hospital found that moderate-intensity statin combined with ezetimibe effectively controlled low-density lipoprotein (LDL) cholesterol levels with lower risks of medication discontinuation, compared to monothera
An increasing number of Korean children aged six or younger are suffering from adenovirus infections, presenting cold symptoms like fever, cough, and pink eye, the government said. According to the Korea Disease Control and Prevention Agency (KDCA), the number of hospitalized individuals with adenov
Neofect, a Korean company specializing in digital rehabilitation, said on Tuesday that it signed an R&D agreement with the Korea Medical Device Development Foundation (KMDF) to apply artificial intelligence (AI) technologies to develop digital smart boards for patient rehabilitation. Neofect produce
The bustling city of Seoul is all set to host the 16th annual meeting of the Korean Society of Medical Oncology (KSMO) International Conference from Sept. 7-8 at Grand Walkerhill Seoul.With the conference becoming an international event in 2019, this significant gathering has become a hallmark globa
On Monday, ATsens announced the initiation of prescriptions for its long-term continuous electrocardiogram (ECG) monitoring device, AT-Patch, in Japan. This announcement follows just one week after Huinno, another domestic ECG patch manufacturer, revealed a partnership to jointly promote its ECG pat
Drug price negotiations for two spinal muscular atrophy (SMA) drugs --Spinraza (nusinersen) and Evrysdi (risdiplam) – have reportedly failed to settle by the deadline, deepening the concerns of Korean patients, according to sources Monday.The National Health Insurance Service (NHIS) failed to narrow
HK inno.N's anti-cancer drug targeting non-small cell lung cancer (NSCLC) has been selected by the Korea Drug Development Foundation (KDDF) as part of the "New Drug R&D Ecosystem Building Research" project.The project is a cross-sectoral R&D program where the KDDF supports the entire life cycle of n
A group of doctors called for allowing "telemonitoring" of arrhythmia patients with devices implanted to detect pulses in the heart. They argued that remote monitoring is a medical treatment process and not an act of medical treatment.At a news conference last Wednesday, the Korean Heart Rhythm Soci
Genome&Company, a prominent name in the microbiome domain, has underscored its robust progress in the realm of cancer research. Genome&Company co-CEO Pae Ji-soo said the company would seek a technology transfer for two of its anticancer candidates by the year's end. This decision is attributed to du
JW Shinyak said it will resume sales of SK bioscience's influenza vaccine, SKY Cellflu Quardrivalent Prefilled Syringe.SKY Cellflu Quardrivalent is a cell-culture influenza vaccine developed by SK bioscience that protects against four types of influenza viruses -- including two types of influenza A
The U.S. Food and Drug Administration recently decided to increase user fees for fiscal year 2024.On July 28, the FDA finalized and announced user fees for new drugs (specialty drugs), generics, biosimilars, and medical devices, increasing the first three. The FDA will apply these fees from October